Literature DB >> 21458469

Enhanced long-term depression and impaired reversal learning in phosphodiesterase 4B-knockout (PDE4B-/-) mice.

Kris Rutten1, Tanya L Wallace, Melissa Works, Jos Prickaerts, Arjan Blokland, Thomas J Novak, Luca Santarelli, Dinah L Misner.   

Abstract

3'-5'-Cyclic adenosine monophosphate (cAMP) is known to be an important regulator of synaptic plasticity. The effects of cAMP are mediated through downstream effectors such as protein kinase A (PKA), Ca(2+) and cAMP-response element binding protein (CREB). The phosphodiesterase 4 (PDE4) family of enzymes, which is comprised of four genes and at least 25 protein isoforms, mediates the hydrolysis of cAMP, yet little is presently known about the contribution of specific PDE4 isoforms to synaptic plasticity and cognitive behavior. The purpose of the present studies was to determine the contribution of the PDE4B gene in mediating synaptic plasticity and cognitive behavior. Electrophysiological recordings from hippocampal slice preparations of mice deficient in the PDE4B gene (PDE4B(-/-)) showed that knockout animals displayed markedly enhanced basal postsynaptic responses to stimulation and long-term depression as compared to wild-type littermates. Interestingly, no genotypic differences were noted in long-term potentiation experiments following several different induction protocols. On the behavioral level PDE4B(-/-) mice displayed impaired reversal learning in the Morris water maze compared to wild-type littermates, but no differences in acquisition and retention of spatial memory and fear conditioning. Taken together, these results suggest that the PDE4B gene may play a role in synaptic activity and long-term depression and is involved in spatial reversal memory. Our findings support the view that various PDE4 isoforms are non-redundant and have distinct neurological roles.
Copyright © 2011 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21458469     DOI: 10.1016/j.neuropharm.2011.03.020

Source DB:  PubMed          Journal:  Neuropharmacology        ISSN: 0028-3908            Impact factor:   5.250


  19 in total

Review 1.  PDE4 as a target for cognition enhancement.

Authors:  Wito Richter; Frank S Menniti; Han-Ting Zhang; Marco Conti
Journal:  Expert Opin Ther Targets       Date:  2013-07-25       Impact factor: 6.902

2.  Repeated shock stress facilitates basolateral amygdala synaptic plasticity through decreased cAMP-specific phosphodiesterase type IV (PDE4) expression.

Authors:  Steve Ryan; Chenchen Li; Aurélie Menigoz; Rimi Hazra; Joanna Dabrowska; David Ehrlich; Katelyn Gordon; Donald G Rainnie
Journal:  Brain Struct Funct       Date:  2017-12-04       Impact factor: 3.270

Review 3.  Phosphodiesterase regulation of alcohol drinking in rodents.

Authors:  Marian L Logrip
Journal:  Alcohol       Date:  2015-05-29       Impact factor: 2.405

Review 4.  Phosphodiesterases as therapeutic targets for Alzheimer's disease.

Authors:  Ana García-Osta; Mar Cuadrado-Tejedor; Carolina García-Barroso; Julen Oyarzábal; Rafael Franco
Journal:  ACS Chem Neurosci       Date:  2012-10-01       Impact factor: 4.418

5.  Chronic Cognitive Dysfunction after Traumatic Brain Injury Is Improved with a Phosphodiesterase 4B Inhibitor.

Authors:  David J Titus; Nicole M Wilson; Julie E Freund; Melissa M Carballosa; Kevin E Sikah; Concepcion Furones; W Dalton Dietrich; Mark E Gurney; Coleen M Atkins
Journal:  J Neurosci       Date:  2016-07-06       Impact factor: 6.167

6.  A biphasic and brain-region selective down-regulation of cyclic adenosine monophosphate concentrations supports object recognition in the rat.

Authors:  Maïte Hotte; François Dauphin; Thomas Freret; Michel Boulouard; Guenaëlle Levallet
Journal:  PLoS One       Date:  2012-02-16       Impact factor: 3.240

7.  Specific Inhibition of Phosphodiesterase-4B Results in Anxiolysis and Facilitates Memory Acquisition.

Authors:  Alexander McGirr; Tatiana V Lipina; Ho-Suk Mun; John Georgiou; Ahmed H Al-Amri; Enoch Ng; Dongxu Zhai; Christina Elliott; Ryan T Cameron; Jonathan G L Mullins; Fang Liu; George S Baillie; Steven J Clapcote; John C Roder
Journal:  Neuropsychopharmacology       Date:  2015-08-14       Impact factor: 7.853

8.  Comparison of the Pharmacological Profiles of Selective PDE4B and PDE4D Inhibitors in the Central Nervous System.

Authors:  Chong Zhang; Ying Xu; Han-Ting Zhang; Mark E Gurney; James M O'Donnell
Journal:  Sci Rep       Date:  2017-01-05       Impact factor: 4.379

9.  Phosphodiesterase Inhibition and Regulation of Dopaminergic Frontal and Striatal Functioning: Clinical Implications.

Authors:  Pim R A Heckman; Marlies A van Duinen; Eva P P Bollen; Akinori Nishi; Lawrence P Wennogle; Arjan Blokland; Jos Prickaerts
Journal:  Int J Neuropsychopharmacol       Date:  2016-04-02       Impact factor: 5.176

10.  Altered phosphorylation, electrophysiology, and behavior on attenuation of PDE4B action in hippocampus.

Authors:  Susan L Campbell; Thomas van Groen; Inga Kadish; Lisa High Mitchell Smoot; Graeme B Bolger
Journal:  BMC Neurosci       Date:  2017-12-02       Impact factor: 3.288

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.